10/2 12:05-13:25（301）
Satellite Symposium (IX)
-- Abbvie
What shall we consider when DAAs arrive globally? Who shall we cure?
| Time | Topic | Speaker | Moderator |
|---|---|---|---|
| Opening |
Rong-Nan Chien 簡榮南
Keelung Chang Gung Memorial Hospital 基隆長庚醫院
|
||
| How do Direct Antiviral Agents (DAAs) show as new solutions post-Peg interferon era? |
Chun-Jen Liu 劉俊人
National Taiwan University Hospital 台大醫院
|
Ming-Shiang Wu 吳明賢
National Taiwan University Hospital 台大醫院
|
|
| Clinical considerations for special populations among HCV infected patients |
Ming-Ling Chang 張明鈴
Linkou Chang Gung Memorial Hospital 林口長庚醫院
|
Rong-Nan Chien 簡榮南
Keelung Chang Gung Memorial Hospital 基隆長庚醫院
|
|
| The earlier the treatment, the better the outcome (Advance Liver Disease) |
Tsung-Hui Hu 胡琮輝
Kaohsiung Chang Gung Memorial Hospital 高雄長庚醫院
|
Rong-Nan Chien 簡榮南
Keelung Chang Gung Memorial Hospital 基隆長庚醫院
|
|
| Panel discussion | All speakers | ||
| Closing |
Rong-Nan Chien 簡榮南
Keelung Chang Gung Memorial Hospital 基隆長庚醫院
|
||